Precision Optics reported Q1 2027 revenue growth of 22% year-over-year to $8.2 million, driven by strong performance in satellite optical communications and single-use medical device programs. The company's net loss narrowed significantly to $0.5 million compared to $1.6 million in the prior year, while gross margins improved to 22.5%.
Term
Q1 2027
“Revenue grew 22% year over year to $8.2 million, led by a 23% increase in production revenue. Higher volumes and more efficient manufacturing helped lift gross margin and improved our Adjusted EBITDA.”
Dr. Joe Forkey, CEO of Precision Optics
“We continued to make operational progress with our single-use medical device programs. The cystoscope program generated $1.8 million in production revenue, and our ophthalmic program delivered revenue of $581,000, as shipments increased under its $3.5 million follow-on order.”
Precision Optics Corporation reported revenues of $8.15 million for the quarter ended September 30, 2026, a 22% increase compared to the prior year. Despite the revenue growth and a significantly improved gross profit of $1.84 million, the company recorded a net loss of $474,854, which was a substantial reduction from the $1.64 million loss in the same period of 2025.
Precision Optics Corporation entered into a new one-year lease agreement with Equity Assets, Inc. for its existing 12,292 square foot facility in Gardner, Massachusetts. The lease commenced July 1, 2026, with monthly rent starting at $13,316.33 and includes two one-year extension options.
Precision Optics reported record fiscal year 2026 revenue of $31.5 million, a 65% increase year-over-year, driven by a doubling of production revenue to $28.1 million. While the company reported a net loss of $3.6 million for the year, it significantly improved its cash position to $9.8 million and issued FY 2027 revenue guidance of $30 million to $33 million.